MBX Biosciences Ratios (2023-2026) | MBX

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter) 275.47M257.23M238.72M315.80M392.61M418.92M
Equity Average (Quarter) -68.64M-77.76M-90.47M86.74M264.40M246.43M227.33M303.39M378.38M403.49M
Invested Capital (Quarter) -64.82M-72.47M-83.05M-97.89M271.37M257.44M235.42M219.24M387.54M369.22M437.76M
Leverage & Solvency
Equity Ratio (Quarter) -0.860.960.960.960.950.970.960.97
Valuation
Enterprise Value (Quarter) 115.86M35.18M36.50M36.50M-277.06M-262.15M-240.79M-224.91M-391.67M-373.70M-439.98M
Return Ratios
Return on Capital Employed (Quarter) -25.79%-32.99%-38.14%-29.92%-26.00%-24.43%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%